LifeStance Health Group Inc (LFST) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
LifeStance Health Group, Inc. (LFST)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Revenue: $382 million for Q4, a 17% year-over-year increase; $1.424 billion for the full year, up 14% year-over-year. Visit Volumes: 2.4 million visits in Q4, an 18% year-over-year increase. Clinician Growth: Net addition of 44 clinicians in Q4 and 657 for the full year, totaling 8,040 clinicians, a 9% year-over-year increase. Total Revenue per Visit: $160, roughly flat year-over-year. Center Margin: $126 million in Q4, a 15% year-over-year increase; $461 million for the full year, up 15%. Adjusted EBITDA: $49 million in Q4, a 49% year-over-year increase; $158 million for the full year, up 32% year-over-year. Free Cash Flow: $47 million in Q4; $110 million for the full year. Cash Position: $249 million at the end of the quarter. Net Long-term Debt: $266 million. Share Repurchase Program: Authorized up to $100 million. 2026 Revenue Guidance: $1.615 billion to $1.655 billion. 2026 Center Margin Guidance: $526 million to $
Show less
Read more
Impact Snapshot
Event Time:
LFST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFST alerts
High impacting LifeStance Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
LFST
News
- LifeStance Health Group (LFST) had its price target raised by Canaccord Genuity Group Inc. from $9.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- LifeStance Health Group (LFST) had its price target raised by UBS Group AG from $10.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- LifeStance Health Group (LFST) had its price target raised by KeyCorp from $8.00 to $9.00. They now have an "overweight" rating on the stock.MarketBeat
- LifeStance Health Group Announces Launch of Secondary Public OfferingGlobeNewswire
- LifeStance Health Group, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
LFST
Earnings
- 2/25/26 - Beat
LFST
Sec Filings
- 2/27/26 - Form 424B7
- 2/26/26 - Form 424B7
- 2/25/26 - Form S-8
- LFST's page on the SEC website